A randomized control study for evaluating the efficacy of individualized homoeopathic medicine as an adjuvant therapy in mild to moderate cases of COVID-19
Journal of Integrated Standardized Homoeopathy · 2021
DOI: 10.25259/jish_15_2021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrated Standardized Homoeopathy, 2021. Verfasst von Shirish Kamlakar Phansalkar und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Understanding the efficacy of indicated homoeopathic medicine as an adjuvant to standard treatment in improving the subjective and objective parameters in patients with mild to moderate confirmed cases of COVID-19. Materials and Methods: Study design: A prospective randomized control trial conducted at Deenanath Mangeshkar Hospital, Erandwane, Pune, wherein Group A received standard treatment along with indicated homoeopathic medicine (experimental group) and Group B received the standard treatment and placebo (control group). Sample size: Fifty confirmed COVID positive, randomly selected patients in Groups A and B.
Results
The indicated homoeopathic medicine as an adjuvant reduced subjective distress in a statistically significant proportion. It also reduced oxygen requirement, shortened hospital stay, promoted early recovery, and reduced worsening of the patients and shifting into the intensive care unit (ICU). By day 4 of treatment, subjective symptoms in 56% of patients in the experimental group were completely resolved, compared to 15% in the control group. The oxygen requirement on day 4 reduced by 46.2% in the experimental group, remaining unchanged in the control group. None of the patients in the experimental group needed shifting to the ICU compared to 16.7% in the control group. The average hospital stay was 6 days in the experimental group, compared to 9 days in the control group.
Conclusion
Homoeopathic medicines played a significant role in helping to relieve the subjective and objective parameters of COVID-19.
Zitieren
APA
Phansalkar, S. K., Pacharne, T. D., Somawanshi, N. H., & Parekh, B. R. (2021). A randomized control study for evaluating the efficacy of individualized homoeopathic medicine as an adjuvant therapy in mild to moderate cases of COVID-19. Journal of Integrated Standardized Homoeopathy. https://doi.org/10.25259/jish_15_2021
Vancouver
Phansalkar SK, Pacharne TD, Somawanshi NH, Parekh BR. A randomized control study for evaluating the efficacy of individualized homoeopathic medicine as an adjuvant therapy in mild to moderate cases of COVID-19. Journal of Integrated Standardized Homoeopathy. 2021. doi:10.25259/jish_15_2021
BibTeX
@article{Phansalkar2021,
author = {Phansalkar, Shirish Kamlakar and Pacharne, Tejaswini Deoram and Somawanshi, Navnath Hanumant and Parekh, Bhavik Ramesh},
title = {A randomized control study for evaluating the efficacy of individualized homoeopathic medicine as an adjuvant therapy in mild to moderate cases of COVID-19},
journal = {Journal of Integrated Standardized Homoeopathy},
year = {2021},
doi = {10.25259/jish_15_2021}
}
EUVIMED